Photo of Marc-Aurel Fuchs

Marc-Aurel Fuchs

Mr

20132017
If you made any changes in Pure these will be visible here soon.

Research Output 2013 2017

  • 4 Article
  • 2 Conference contribution
Filter
Conference contribution
2016

ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

Weir, J-A., Gilliland, P., Fuchs, M-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Colorectal Neoplasms
Therapeutics
Ligands
ADAM17 Protein
Cetuximab

Validation of a MEK/MET-specific NGS panel for early phase trial interrogation

Maxwell, P., del favero, J., Fuchs, M-A., Tabernero, J., Maughan, T., Middleton, M., Adams, R., Rolfo, C., Hennessy, B. T., Laurent=puig, P., Bardelli, A., Andre, T., Popovici, V., Johnston, P., Wilson, R., Lawler, M., Van Schaeybroeck, S. & Salto-Tellez, M., 01 May 2016, Validation of a MEK/MET-specific NGS panel for early phase trial interrogation . Proceedings: AACR Annual Meeting 2016; April 16-20 New Orleans, Vol. abstract 1396.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Mitogen-Activated Protein Kinase Kinases
Computational Biology
Exons
Mutation
Genes